CN105866321B - A kind of thin-layer identification method of CORTEX KALOPANACIS granule - Google Patents

A kind of thin-layer identification method of CORTEX KALOPANACIS granule Download PDF

Info

Publication number
CN105866321B
CN105866321B CN201610440849.XA CN201610440849A CN105866321B CN 105866321 B CN105866321 B CN 105866321B CN 201610440849 A CN201610440849 A CN 201610440849A CN 105866321 B CN105866321 B CN 105866321B
Authority
CN
China
Prior art keywords
thin
granule
reference substance
solution
cortex kalopanacis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610440849.XA
Other languages
Chinese (zh)
Other versions
CN105866321A (en
Inventor
周厚成
胡昌江
周维
冯健
李文兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan New Green Pharmaceutical Technology Development Co Ltd
Original Assignee
Sichuan New Green Pharmaceutical Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan New Green Pharmaceutical Technology Development Co Ltd filed Critical Sichuan New Green Pharmaceutical Technology Development Co Ltd
Priority to CN201610440849.XA priority Critical patent/CN105866321B/en
Publication of CN105866321A publication Critical patent/CN105866321A/en
Application granted granted Critical
Publication of CN105866321B publication Critical patent/CN105866321B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90Plate chromatography, e.g. thin layer or paper chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N2030/062Preparation extracting sample from raw material

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

The present invention relates to Pharmaceutical Analysis technical field, specially a kind of thin-layer identification method of CORTEX KALOPANACIS granule.This method is:Take 0.5g particles finely ground, plus ultrasonically treated, filtration after methanol, filtrate adds to be heated to reflux 1 hour after hydrochloric acid, is evaporated, residue adds methanol 1ml to make dissolving, as need testing solution, separately take oleanolic acid, hederagenin reference substance appropriate, plus reference substance solution is made in methanol.Each 3 μ l of above two solution are drawn, are put respectively on same silica gel g thin-layer plate, using cyclohexane ethyl acetate glacial acetic acid as solvent, deploys, takes out, dry, spray with ethanol solution of sulfuric acid, spot development is heated at 105 DEG C clearly, puts and is inspected under ultraviolet lamp.In test sample chromatogram, on position corresponding with reference substance chromatogram, show the fluorescence spot of same color.As a result thin-layer chromatography clear spot, reappearance is preferable.

Description

A kind of thin-layer identification method of CORTEX KALOPANACIS granule
Technical field
The present invention relates to Pharmaceutical Analysis technical field, specially a kind of thin-layer identification method of CORTEX KALOPANACIS granule.
Background technology
CORTEX KALOPANACIS be Araliaceae kalopanax septemlobus, or burr Chinese catalpa dry bark.The bark can be harvested whole year, strip bark, Dry, can wind-damp dispelling, dredging collateral, analgesic.For rheumatoid arthritis.Lumbocrural pain;It is used for traumatic injury outside.It is frequently grown on mountain In ground sparse woods, Anhui, Hubei, Hunan or Guangxi are originated in.
For the domestic rare report of correlative study of CORTEX KALOPANACIS, current pharmacopeia and each province's Chinese medicine standard are without CORTEX KALOPANACIS Thin layer differentiates project appearance, and CORTEX KALOPANACIS granule similarly lacks thin layer and differentiates item, and only indivedual research and development units have it certainly Oneself discrimination method.Contain the compositions such as saponin(e, polyyne, phenylpropyl alcohol alkanes, lignanoid and simple phenolic glycoside in CORTEX KALOPANACIS granule.Soap Methods of glycosides is its main component, and wherein kalopanax septemlobus saponin A has significant anti-inflammatory activity, and it can obtain ivy soap after hydrolyzing Aglycon and oleanolic acid.In existing discrimination method:The preparation process of need testing solution contains ultrasound, water-saturated n-butanol extraction Take 3 times, backflow, chloroform extraction 2 times, operating process is cumbersome, it is a large amount of to use the organic toxic agent chloroform of the first kind.Together When this method only pointed out a principal component-hederagenin.The carry out thin layer discriminating that can not be completely determined.
The content of the invention
The present invention exactly for above technical problem there is provided it is a kind of can quickly, multi information enters to CORTEX KALOPANACIS granule Row thin layer mirror method for distinguishing.
The concrete technical scheme of the present invention is as follows:
A kind of thin-layer identification method of CORTEX KALOPANACIS granule, this method comprises the following steps:
(1)Take CORTEX KALOPANACIS medicinal material granule appropriate, proper amount of methanol is added after grinding, uses power for 600W, frequency is Filtered after 40kHz ultrasonically treated certain times, preferably 30 minutes time, appropriate hydrochloric acid, the matter of hydrochloric acid are added in obtained filtrate Amount concentration is 36%-38%, is evaporated after being heated to reflux, and methanol dissolving is added in the residue after being evaporated, need testing solution is made;
(2)It is another to take oleanolic acid, hederagenin reference substance appropriate, plus every 1ml is made after methanol respectively containing the molten of 0.3mg Liquid, is used as reference substance solution;
(3)On silica gel g thin-layer plate, using cyclohexane-ethyl acetate-glacial acetic acid as solvent, deploy, take out, dry, spray With 10v/v% ethanol solution of sulfuric acid;
(3)Spot development is heated at 100-108 DEG C clear, preferably 105 DEG C, puts and inspected under 365nm ultraviolet lamps.
Preferably, step(1)Specially:Take CORTEX KALOPANACIS medicinal material granule appropriate, it is finely ground, take 0.5g, plus methanol 20ml, uses power for 600W, and frequency is 40kHz ultrasonically treated 30 minutes, filtration, and filtrate adds hydrochloric acid(The quality percentage of hydrochloric acid Concentration is 36%-38%)2ml, is heated to reflux 1 hour, is evaporated, residue adds methanol 1ml to make dissolving, as need testing solution,
Described solvent is cyclohexane-ethyl acetate-glacial acetic acid, with volume basis, hexamethylene:Ethyl acetate:Ice vinegar Acid=4-7:2-5:0.2-0.35, preferably with volume basis, hexamethylene:Ethyl acetate:Glacial acetic acid=6:4:0.25.
The ultrasonically treated power is 600W, and frequency is 40kHz.
The positive effect of the present invention is embodied in:
(One), can quickly, multi information to CORTEX KALOPANACIS granule carry out thin layer discriminating.
(Two), test sample solvent preparation only comprising two processes of ultrasound and backflow, operating process is simple and convenient.
(Three), need testing solution preparation and solvent in not use the big organic solvent of toxicity, practical guarantor The healthy of operating personnel has been protected, the pollution of environment is reduced.
(Four), the present invention pointed out two known chemical compositions, i.e. oleanolic acid and hederagenin, greatly increase The specificity of method is added.
(Five), temperature on CORTEX KALOPANACIS granule sample solution thin layer differentiate without influence, illustrate that the thin-layer identification method is resistance to It is good with property;Humidity differentiates without influence on CORTEX KALOPANACIS granule sample thin layer, illustrates the thin-layer identification method good tolerance; Thin-layer identification method has preferable durability, and favorable reproducibility.
Brief description of the drawings
Fig. 1 is that the thin layer of test sample and reference substance in embodiment differentiates chromatogram;
Wherein 1 it is oleanolic acid, 2 is that hederagenin, 3-5 are CORTEX KALOPANACIS granule 1409065.
Fig. 2 is that the thin layer that CORTEX KALOPANACIS granule point sample amount different with reference substance is investigated differentiates chromatogram;
Wherein 1 it is the μ l of reference substance solution 1,2 be the μ l of reference substance solution 2,3 be the μ l of reference substance solution 3,4 is reference substance solution 4 μ l, 5 be the μ l of CORTEX KALOPANACIS granule 1,6 be the μ l of CORTEX KALOPANACIS granule 2,7 be the μ l of CORTEX KALOPANACIS granule 3,8 be that CORTEX KALOPANACIS is matched somebody with somebody The square μ l of particle 4.
Fig. 3 is CORTEX KALOPANACIS granule thin-layer chromatogram, and its T is 21 DEG C, and RH is 45%;
Wherein, 1 it is reference substance solution, 2 is that negative sample, 3-5 are CORTEX KALOPANACIS granule 1409065.
Fig. 4 is the thin layer discriminating chromatogram of CORTEX KALOPANACIS granule under normal temperature condition;Its T is 21 DEG C, and RH is 45%;
Wherein 1 is that reference substance, 2-4 are CORTEX KALOPANACIS particle 1409065.
Fig. 5 is CORTEX KALOPANACIS granule thin layer discriminating chromatogram under cryogenic conditions;Its T is 6 DEG C, and RH is 31%;
Wherein 1 is that reference substance, 2-4 are CORTEX KALOPANACIS particle 1409065.
Fig. 6 is CORTEX KALOPANACIS granule thin layer discriminating chromatogram under super-humid conditions;Its T is 21 DEG C, and RH is 75%;
Wherein 1 is that reference substance, 2-4 are CORTEX KALOPANACIS particle 1409065.
Fig. 7 is CORTEX KALOPANACIS granule thin layer discriminating chromatogram under low humidity conditions;Its T is 21 DEG C, and RH is 20%;
Wherein 1 is that reference substance, 2-4 are CORTEX KALOPANACIS particle 1409065.
Fig. 8 difference silica G plates(Qingdao Haiyang)Thin layer differentiates chromatogram, and its T is 21 DEG C, and RH is 45%;
Wherein 1 is that reference substance, 2-4 are CORTEX KALOPANACIS particle 1409065.
Fig. 9 is different silica G plates(Qingdao spectrum section)Thin layer differentiates chromatogram, and its T is 21 DEG C, and RH is 45%;
Wherein 1 is that reference substance, 2-4 are CORTEX KALOPANACIS particle 1409065.
Figure 10 is each validation batches TLC figures of CORTEX KALOPANACIS granule,
Wherein 1 be reference substance solution, 2 be 1109015,3 be 1103042,4 be 1401019,5 be 1409065.
Figure 11 is the thin layer discriminating chromatogram that embodiment part changes need testing solution after solvent.
Embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, with reference to embodiment pair The present invention is described in further detail, but this should not be interpreted as to the scope of above-mentioned theme of the invention is only limitted to following implementations Example.
1st, instrument and reagent
Instrument:Thin layer automated imaging instrument(CAMAG TLC VISUALIZER), the semi-automatic point samples of linamat5- CAMAG Instrument, a ten thousandth balance(Sai Duolisi BS110S), KQ-250B type ultrasonic cleaning machines(Kunshan ultrasonic electronic Co., Ltd)、 Testing chamber for medicine stability(Shanghai Yiheng Scientific Instruments Co., Ltd), silica gel g thin-layer plate(The limited public affairs of Tianjin Si Lida science and technology Department, can clipboard, lot number:130508), silica gel g thin-layer plate(Qingdao makes people rich source silica gel chemical reagent work, glass plate, lot number: 141201), silica gel g thin-layer plate(Subsidiary factory of Haiyang Chemical Plant, Qingdao, glass plate, lot number:20130701).
Reagent:CORTEX KALOPANACIS granule(Lot number:1409065,1401019,1109015,1409065, Sichuan new green medicine Industry sci-tech development Co., Ltd.);
Oleanolic acid(110709-201206, Chinese pharmaceutical biological product identifies institute);Hederagenin(111733- 201205, Chinese pharmaceutical biological product identifies institute);
Hexamethylene, ethyl acetate, glacial acetic acid etc. are that analysis is pure.
2nd, the preparation of solution
The preparation of 2.1 need testing solutions
Take this product appropriate, it is finely ground, 0.5g, plus methanol 20ml are taken, power is used for 600W, frequency is at 40kHz ultrasound Reason 30 minutes, filtration, filtrate adds hydrochloric acid(Mass percentage concentration is 36%-38%)2ml, is heated to reflux 1 hour, is evaporated, residue adds Methanol 1ml makes dissolving, is used as need testing solution.
The preparation of 2.2 reference substance solutions
Take oleanolic acid, hederagenin reference substance appropriate, plus every 1ml respectively solution containing 0.3mg is made in methanol, as Reference substance solution.
It is prepared by 2.3 negative control solutions
Take maltodextrin 0.5g, plus methanol 20ml, it is ultrasonically treated(Power 600W, frequency 40kHz)30 minutes, filter, filter Liquid adds hydrochloric acid(36%-38%)2ml, is heated to reflux 1 hour, is evaporated, residue adds methanol 1ml to make dissolving, be used as negative sample solution.
3rd, thin-layer chromatography condition
Lamellae:Silica gel g thin-layer plate
Solvent:Cyclohexane-ethyl acetate-glacial acetic acid (6:4:0.25)
Inspect:Spray is heated to spot development at 105 DEG C clearly, is put ultraviolet lamp (365nm) with 10% ethanol solution of sulfuric acid Under inspect.
As a result:In test sample chromatogram, with reference substance chromatogram on a corresponding position, show the fluorescence spot of same color(See Fig. 1).
4th, different point sample amounts are investigated
Draw CORTEX KALOPANACIS granule need testing solution(Lot number:1409065)The different μ l of point sample amount 1,2,3,4, reference substance The μ l of solution difference point sample amount 1,2,3,4, point sample is on same silica gel g thin-layer plate respectively, with cyclohexane-ethyl acetate-glacial acetic acid Volume ratio be 6:4:0.25 is solvent, is deployed, and takes out, dries, and spray is with 10wt% ethanol solution of sulfuric acid, in 105 DEG C of heating It is clear to spot development, inspected under the ultraviolet lamp for putting 365nm, experimental result is shown in Fig. 2, from Figure 2 it can be seen that CORTEX KALOPANACIS granule In need testing solution chromatogram, the spot of same color is shown on position corresponding with reference substance chromatogram.CORTEX KALOPANACIS granule is supplied When the point sample amount of test sample solution is that 3 μ l, the point sample amount of CORTEX KALOPANACIS reference substance solution are 3 μ l, clear spot and do not trail.Therefore, The point sample amount of CORTEX KALOPANACIS granule need testing solution is 3 μ l, and the point sample amount of reference substance solution is 3 μ l.
5th, CORTEX KALOPANACIS granule specificity is investigated
Draw respectively CORTEX KALOPANACIS granule need testing solution, reference substance solution and negative control solution difference point sample in On same silica gel g thin-layer plate, deploy by above-mentioned thin-layer chromatography condition, take out, dry, spray with 10wt% ethanol solution of sulfuric acid, 105 DEG C are heated to spot development clearly, are inspected under the ultraviolet lamp for putting 365nm, experimental result is shown in Fig. 3.As seen from Figure 3, river paulownia In skin granule need testing solution chromatogram, the spot of same color is being shown with the relevant position of reference substance reference substance chromatogram, and Negative sample is noiseless.
Further, since the medicinal material containing hederagenin includes:Field pennycress, the root of Chinese clematis, honeysuckle, Akebia Fruit etc., if Only the hederagenin in CORTEX KALOPANACIS granule is considered, although even if the figure that last thin layer is identified is represented Go out, the relevant position of need testing solution and reference substance reference substance chromatogram shows the spot of same color, still not can determine that and identifies The medicinal material come is CORTEX KALOPANACIS granule.
6. different temperatures is investigated
CORTEX KALOPANACIS granule need testing solution and reference substance solution point are drawn respectively on same silica G plate, by upper Thin-layer chromatography condition is stated, is deployed respectively under normal temperature and cryogenic conditions, takes out, dries, is sprayed with 10wt% ethanol solution of sulfuric acid, 105 DEG C are heated to spot development clearly, are inspected under the ultraviolet lamp for putting 365nm, thin-layer chromatogram is shown in Fig. 4-Fig. 5.By Fig. 4 and figure 5 is visible, under normal temperature and cryogenic conditions, in CORTEX KALOPANACIS granule test sample chromatogram, shows phase in relevant position with reference substance chromatogram With the fluorescence spot of color.And CORTEX KALOPANACIS granule test sample chromatogram spot separating effect is preferable.Test result indicates that, temperature CORTEX KALOPANACIS granule sample solution thin layer is differentiated without influence, illustrates the thin-layer identification method good tolerance.
7. different humidity is investigated
CORTEX KALOPANACIS granule need testing solution and CORTEX KALOPANACIS reference substance solution point are drawn respectively in same silica G plate On, by above-mentioned thin-layer chromatography condition, by above-mentioned thin-layer chromatography condition, deploy respectively under the conditions of 75% and 20% different humidity, Take out, dry, spray with 10wt% ethanol solution of sulfuric acid, spot development is heated at 105 DEG C clearly, 365nm ultraviolet lamp is put Under inspect, test result and see Fig. 6~Fig. 7.Under Fig. 6 and Fig. 7, high humidity and low-moisture conditions, CORTEX KALOPANACIS granule is for examination In product chromatogram, show the fluorescence spot of same color in relevant position with reference substance chromatogram.CORTEX KALOPANACIS granule under different humidity Sample chromatogram spot separating effect is all preferable.Test result indicates that, humidity differentiates without shadow to CORTEX KALOPANACIS granule sample thin layer Ring, illustrate the thin-layer identification method good tolerance.
8th, the comparison of different lamellaes
CORTEX KALOPANACIS granule solution, CORTEX KALOPANACIS reference substance solution point are drawn respectively in different manufacturers(Qingdao Haiyang chemical industry Subsidiary factory of factory, Tianjin ENBREL reach Science and Technology Ltd.)On silica gel g thin-layer plate, deploy by above-mentioned thin-layer chromatography condition, take out, dry, Spray is heated to spot development at 105 DEG C clearly, inspected under the ultraviolet lamp for putting 365nm with 10% ethanol solution of sulfuric acid;Thin layer color Spectrogram is shown in Fig. 8~Fig. 9.From the silica gel g thin-layer plate of Fig. 8-9, two different manufacturers production to the equal energy of CORTEX KALOPANACIS granule Play good separating effect.And in CORTEX KALOPANACIS granule test sample chromatogram, phase is shown on position corresponding with reference substance chromatogram With the fluorescence spot of color.Experimental result illustrates that the thin-layer identification method has preferable durability.
9. different batches sample thin layer differentiates comparative study
The CORTEX KALOPANACIS granule of different batches is differentiated using thin-layer identification method described in text, experimental result table Bright, in test sample chromatogram, each batch CORTEX KALOPANACIS granule shows the glimmering of same color on position corresponding with reference substance chromatogram Hot spot point, reappearance is preferable.
10. the comparative study that different solvents differentiate to sample thin layer
Will with afore-mentioned test with batch CORTEX KALOPANACIS granule using preceding method carry out need testing solution, method with In the case that step is consistent, only changes the composition of solvent, i.e., the n-hexane in solvent is changed to the hexamethylene of equivalent, then Thin layer discriminating is carried out to need testing solution, experimental result is shown in Figure 11:Test result indicates that, the thin-layer chromatogram shows ivy soap Aglycon principal spot with it is following close to spot be not totally separated from, and its Rf value be 0.18, less than 2015 versions《Middle traditional Chinese medicines Allusion quotation》Regulation of the Rf value between 0.2-0.8 in 4th general rule 0502.Therefore development system n-hexane-acetic acid second in the document Ester-glacial acetic acid is not equal with cyclohexane-ethyl acetate-glacial acetic acid, and n-hexane can not directly replace with hexamethylene.
The foregoing description of the disclosed embodiments, enables professional and technical personnel in the field to realize or using the present invention. A variety of modifications to these embodiments will be apparent for those skilled in the art, as defined herein General Principle can be realized in other embodiments without departing from the spirit or scope of the present invention.Therefore, it is of the invention The embodiments shown herein is not intended to be limited to, and is to fit to and principles disclosed herein and features of novelty phase one The most wide scope caused.

Claims (2)

1. a kind of thin-layer identification method of CORTEX KALOPANACIS granule, it is characterised in that this method comprises the following steps:
(1)Take CORTEX KALOPANACIS medicinal material granule appropriate, proper amount of methanol is added after grinding, filtered after ultrasonically treated certain time, To filtrate in plus appropriate hydrochloric acid, be evaporated after being heated to reflux, in the residue after being evaporated plus methanol dissolving, be made need testing solution;
(2)It is another to take oleanolic acid, hederagenin reference substance appropriate, plus it is made every 1ml respectively solution containing 0.3mg after methanol, It is used as reference substance solution;
(3)On silica gel g thin-layer plate, using cyclohexane-ethyl acetate-glacial acetic acid as solvent, deploy, take out, dry, spray with 10wt% ethanol solution of sulfuric acid;
(4)Spot development is heated at 100 DEG C -108 DEG C clear, puts and inspected under 365nm ultraviolet lamps;
Step(1)In take CORTEX KALOPANACIS medicinal material granule appropriate, it is finely ground, take 0.5g, plus methanol 20ml, ultrasonically treated 30 minutes, Filtration, filtrate adds hydrochloric acid 2ml, is heated to reflux 1 hour, is evaporated, residue adds methanol 1ml to make dissolving, is used as need testing solution;
Described solvent is cyclohexane-ethyl acetate-glacial acetic acid, with volume basis, hexamethylene:Ethyl acetate:Glacial acetic acid= 4-7:2-5:0.2-0.35;The ultrasonically treated power is 600W, and frequency is 40kHz.
2. the thin-layer identification method of CORTEX KALOPANACIS granule according to claim 1, it is characterised in that:Described solvent is Cyclohexane-ethyl acetate-glacial acetic acid, with volume basis, hexamethylene:Ethyl acetate:Glacial acetic acid=6:4:0.25.
CN201610440849.XA 2016-06-20 2016-06-20 A kind of thin-layer identification method of CORTEX KALOPANACIS granule Active CN105866321B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610440849.XA CN105866321B (en) 2016-06-20 2016-06-20 A kind of thin-layer identification method of CORTEX KALOPANACIS granule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610440849.XA CN105866321B (en) 2016-06-20 2016-06-20 A kind of thin-layer identification method of CORTEX KALOPANACIS granule

Publications (2)

Publication Number Publication Date
CN105866321A CN105866321A (en) 2016-08-17
CN105866321B true CN105866321B (en) 2017-08-29

Family

ID=56651006

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610440849.XA Active CN105866321B (en) 2016-06-20 2016-06-20 A kind of thin-layer identification method of CORTEX KALOPANACIS granule

Country Status (1)

Country Link
CN (1) CN105866321B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113448A (en) * 2021-12-22 2022-03-01 河北万邦复临药业有限公司 Method for identifying diabetes treating granular oleanolic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103026224B (en) * 2010-05-27 2015-07-22 株式会社大赛璐 Sample detection method by thin-layer chromatography, thin-layer chromatography plate, and method for producing same
WO2013095175A1 (en) * 2011-12-20 2013-06-27 Zakrytoe Aktsionernoe Obshchestvo "Biogentechnologies" Method of obtaining stepharine sulfate in the cell culture of stephania glabra tissue, and method of quantitative determination of stepharine sulfate
EP2919004A1 (en) * 2014-03-14 2015-09-16 Merck Patent GmbH Bioassays on modified TLC/HPTLC plates

Also Published As

Publication number Publication date
CN105866321A (en) 2016-08-17

Similar Documents

Publication Publication Date Title
CN101974007B (en) Method for extracting bergenin from traditional Chinese medicine rodgersia podophylla
CN105866321B (en) A kind of thin-layer identification method of CORTEX KALOPANACIS granule
CN102139046B (en) Quality control method for antidotal forsythia tablet
CN113109495B (en) Quality detection method of jujube kernel nerve-soothing capsules based on thin-layer chromatography
CN110927322B (en) Detection method of Huoxiang Zhengqi mixture
Patel et al. Evaluation of anti-asthmatic activity of Glycyrrhiza glabra
Tripathy et al. Phytochemical screening and thin layer chromatographic studies of elaeocarpus ganitrus seed the magical electromagnetic bead (rudraksha)
Charles Dorni et al. UHPLC–Q-ToF-MS-guided enrichment and purification of triterpenoids from Centella asiatica (L.) extract with macroporous resin
CN112730724B (en) Thin-layer identification method for cynanchum glaucescens formula granules
WO2013044570A1 (en) Detection method of medicine for curing mastitis and hyperplasia of mammary glands
CN115260024A (en) Method for preparing high-purity licochalcone A from glycyrrhiza inflata
Liu et al. Capillary electrophoretic analyses of alkaloids in commercial samples of Coptidis Rhizoma
CN108802259B (en) Detection method of bupleurum chinense
CN112697950A (en) Thin-layer chromatography identification method of pyrrosia lingua
CN110426486B (en) Method for identifying Zhejiang ophiopogon root in traditional Chinese medicine preparation
CN111830187B (en) Rapid thin-layer identification method for multiple medicinal flavors in bupleurum tenuifolia granule finished product
CN106501440B (en) The discrimination method of field pennycress in Chinese medicine compound prescription
CN104713979A (en) Thin-layer identification method for Dendrobium officinale
CN113552275B (en) Identification method of bat grass
CN112924593B (en) Detection method for lasting brain strengthening effect
CN113155573B (en) Fructus lycii large-polarity control extract and preparation method and application thereof
CN106770885A (en) A kind of method that licorice ingredient carries out indentification by TLC in Huang powder for clearing lung-heat to a kind of reed mentioned in ancient books
CN113759066B (en) Thin-layer identification method for allium macrostemon test sample
CN111024881B (en) Rapid double-information thin-layer identification method for thesium Chinese medicinal materials, granules and target decoction dry powder
CN118191208A (en) Thin layer identification method for perilla leaf and preparation thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 610000 Sichuan city of Pengzhou province and Town Road No. 279 East

Applicant after: Sichuan new green Pharmaceutical Technology Development Co., Ltd.

Address before: Pengzhou City, Chengdu City, Sichuan Province, and 610000 by Zhen Dong He Road No. 279

Applicant before: Sichuan New-green Pharmaceutical Technology Development Co., Ltd.

COR Change of bibliographic data
GR01 Patent grant
GR01 Patent grant